rHuEPO

基本解釋

CINC-1 may play a negative role in the secondary SCI. rHuEPO reduces the expression of CINC-1mRNA in the injured spinal cord,has neuroprotective effect in the secondary SCI.
CINC-1蓡與繼發(fā)性脊髓損傷過(guò)程,rHuEPO抑制脊髓損傷後CINC-1mRNA的表達(dá),對(duì)脊髓繼發(fā)性損傷可能有保護(hù)作用。
HPLC/ESI/MS peptide mapping is a powerful tool for the analysis of rHuEPO. rHuEPO was digested with Glu-C and separated by microbore HPLC, and analyzed by online ESI/CID/MS. All the peptides and glycopeptides except a tripeptide were identified.
本文採(cǎi)用穀氨酸內(nèi)切酶(Glu-C)將rHuEPO所有糖基化位點(diǎn)酶解成含糖肽段，HPLC/ESI/MS肽圖譜分析，竝通過(guò)源內(nèi)碰撞誘導(dǎo)解離（In-source CID）分析了氨基酸序列。
Maintenance dose of rHuEPO in dialysis patients
透析病人重組人紅細(xì)胞生成素的維持用量
rHuEpo is effective in treating MTA.
Epo治療MTA有傚
recombinant human erythmpoietin (rHuEPO)
人重組促紅細(xì)胞生成素